SosNalghranyanMDMD

Internal Medicine • Key West, FL

Hospital Medicine/Hospitalist, Hematology/Oncology

Primary Care Physician/Hospitalist

Join to view full profile

Dr. Nalghranyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nalghranyan's full profile

Already have an account?

Office
3426 N Roosevelt Blvd
Key West, FL 33040
Phone+1 305-296-0021

Fax+1 305-296-0061

Education & Training

One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
St John's Episcopal Hospital-South ShoreResidency, Internal Medicine, 2014 - 2017
Yerevan State Medical UniversityClass of 2006

Certifications & Licensure

CA State Medical License 2016 - 2026
FL State Medical License 2022 - 2026
MI State Medical License 2023 - 2026
NY State Medical License 2018 - 2026
VA State Medical License 2024 - 2026
NC State Medical License 2024 - 2025
AR State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

22 citations
The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia.
Sos Nalghranyan, Amrit P. Singh, Carolina Schinke
American Journal of Hematology. 2020-02-01
Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
Beka Aroshidze, Sos Nalghranyan, Gregory Gotlieb, Burak Erdinc, Alok Aggarwal
The American Journal of Case Reports. 2021-10-10